All News

    A Look at Mindset, Optimism in Life After Cancer

    August 16th 2022

    As I recover from the traumatic effects of cancer, I’m realizing that success has much to do with mindset and optimism.

    Trodelvy Elicits Significant Survival Improvement in A Group of Patients With Pre-Treated Metastatic Breast Cancer

    August 16th 2022

    The use of Trodelvy was associated with a significant improvement in survival when compared with physician’s choice of chemotherapy in patients with HR-positive, HER2-negative metastatic breast cancer, according to recently announced study findings.

    I Use a Simple Button to Combat Anti-Maskers, Since Cancer Made Me Immunocompromised

    August 16th 2022

    I was shocked at a recent doctor appointment when practically nobody in the office was wearing a mask.

    Unlike With Baseball, There Are No Rules When it Comes to Cancer

    August 16th 2022

    The rules of baseball are fair and as long as you do your best, the outcome is always desirable. But with cancer, there are no rules because cancer does what it likes and constantly changes the game.

    Study to Investigate if Exercise Improves Outcomes, Decreases Chemo Side Effects in Colon Cancer

    August 16th 2022

    A new study will analyze the effect of exercise on chemotherapy tolerability and outcomes in patients with colon cancer.

    Investigational Drug-Chemoradiotherapy Combo Improves Treatment Responses in Patients With Advanced Rectal Cancer

    August 15th 2022

    The researchers hypothesize that treatment with the investigational drug combined with chemoradiotherapy may reduce the need for invasive surgery to remove the rectum and surrounding tissue in this patient population.

    Study to Investigate If Novel Drug Overcomes PARP Inhibitor Resistance in Breast Cancer

    August 15th 2022

    A phase 2 trial will analyze the novel drug ART4215 with Talzenna, a PARP inhibitor, for patients with BRCA-deficient breast cancer.

    How I Keep My Cancer at Bay

    August 15th 2022

    I’m playing the cancer cards dealt to me as best I can, and am trying to stay healthy.

    Patients With Cancer Should Speak Up About Mental Health Struggles if They Don’t Feel Heard, Expert Says

    August 15th 2022

    A psychiatrist advises patients with cancer to speak up about their mental health concerns during cancer treatment, as there are tools that can guide best next steps.

    Carrying My Father’s Torch for Colorectal Cancer Awareness

    August 15th 2022

    After my dad died of colorectal cancer, I knew I had to continue advocacy work in his honor.

    A Guiding Light of Positivity in Oncology

    August 14th 2022

    Janice is an exemplary nurse at Fox Chase Cancer Center and has been a member of various teams across the institution for more than 30 years.

    Going Above and Beyond for Patients With Cancer

    August 13th 2022

    Val always goes above and beyond, and she holds herself to an impeccably high standard.

    Patient Enrollment Expands in Trial Evaluating Novel Drug in Breast Cancer

    August 12th 2022

    After findings from an early-phase trial showed that the novel drug was associated with anti-tumor activity, investigators decided to continue enrolling more patients with ER-positive, HER2-negative metastatic breast cancer.

    A Clinical Trial Helped Me Beat the Odds Against Colorectal Cancer

    August 12th 2022

    The way I saw it was that I could either die from cancer, or from the side effects from the clinical trial. It was a difficult decision to make, but I am glad I chose it.

    Cancer, Bears and Fierce Compassion

    August 12th 2022

    Gender be damned, a mother bear’s “fierce compassion” became my default mode as I cared for my ailing adventure partner and soul mate.

    BBC’s ‘EastEnders’ Star Announces Cancer Diagnosis, Leukemia Survivor Embarks on Nation-Wide Bike Ride to Diversify Transplantation Donors and More

    August 12th 2022

    From “EastEnders” star Samantha Womack announcing her breast cancer diagnosis in a tribute to Olivia Newton-John to a famous fashion designer’s death from liver cancer, here’s what’s happening in the oncology space this week.

    ‘Closed for COVID-19:’ Receiving a Cancer Diagnosis at the Start of COVID-19

    August 12th 2022

    A stage 3 colorectal cancer survivor shares her story of being diagnosed right before the COVID-19 pandemic.

    FDA Grants Accelerated Approval to Enhertu for Subgroup of Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer

    August 11th 2022

    The FDA’s approval of Enhertu marks the first approval of a drug for patients with HER2-mutant unresectable or metastatic non-small cell lung cancer.

    Use of Potentially Inappropriate Medications Associated With Increased Risks for Poor Outcomes in Older Patients With Cancer

    August 11th 2022

    The use of five or more medicines — as well as some drugs that could be deemed inappropriate — may put older patients with cancer at a higher risk for complications, such as weakness.

    FDA Grants Tabrecta a Regular Approval for Certain Patients With Lung Cancer

    August 11th 2022

    The FDA approved Tabrecta for patients with non-small cell lung cancer who have a mutation that led to MET exon 14 skipping.

    Crying Over a Movie, Cancer and Lost Innocence

    August 11th 2022

    “Love Story,” the story about a young woman who falls in love and then dies of cancer, affects me differently now than it did when I was a teenager and no experience with either love or cancer.

    FDA Grants Priority Review to Investigational Drug for a Subtype of Advanced or Metastatic Breast Cancer

    August 11th 2022

    The FDA’s decision to grant the investigational drug elacestrant a priority review for patients with ER-positive, HER2-negative advanced or metastatic breast cancer was based on data that showed the treatment bested standard-of-care in terms of improving survival.

    The 'Flipside' of Tumor Lysis Syndrome Shows Efficacy in Leukemia, Lymphoma

    August 11th 2022

    Although tumor lysis syndrome may be dangerous and fatal if not treated early, experts note that it is a sign of successful treatment in patients with leukemia and lymphoma.

    Imfinzi-Novel Drug Combination Elicits Effective Responses in a Group of Patients With Metastatic Sarcomas

    August 10th 2022

    Treatment with a combination of Imfinzi and the novel drug tremelimumab demonstrated promising results in certain patients with advanced or metastatic sarcoma, which are rare cancers of the bone and soft tissue.

    Abecma Improves Progression-Free Survival in Relapsed/Refractory Multiple Myeloma

    August 10th 2022

    Data from a clinical trial demonstrate a “clear clinical benefit” of using a CAR-T cell therapy in patients with multiple myeloma, according to the drugs manufacturer.

    Be Kind to Yourself in Cancer Survivorship

    August 10th 2022

    I must remember to be kind to myself, and not compare my current abilities to my pre-cancer days.

    Expert Advises Patients With Breast Cancer They Can Forgo Certain Supplements

    August 10th 2022

    Many patients with breast cancer ask about the benefits of the supplement sulforaphane, but a naturopathic doctor advises patients that it is best to get the compound from food rather than supplements.

    Two-Drug Combo Bests Chemotherapy in Front-Line Lung Cancer Treatment

    August 10th 2022

    Imfinzi plus tremelimumab led to better overall survival outcomes compared to standard chemotherapy in patients with metastatic non-small cell lung cancer.

    Keytruda-Lenvima Combo Fails to Top Lenvima Alone in Patients With Unresectable Liver Cancer

    August 9th 2022

    Treatment with Keytruda plus Lenvima did not best Lenvima alone as a first-line treatment option for a group of patients with liver cancer that could not be treated with surgery, according to recently announced study results from a phase 3 clinical trial.

    EGFR C797X Mutation May Lead to Tagrisso Resistance in Patients With Lung Cancer

    August 9th 2022

    According to real-world data, EGFR C797X mutation is deemed the leading resistance mechanism to treatment with Tagrisso in patients with non-small cell lung cancer.

    NEXT PAGE
    PREVIOUS PAGE